Brain natriuretic peptide levels in Kawasaki disease: A case report

Pediatrics International

Volumn 51, Issue 3, 2009, Pages 415-418

  Iwashima, Satoru ^a   Ishikawa, Takamichi ^a   Ohzeki, Takehiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain natriuretic peptide (BNP); Giant coronary aneurysm; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEPARIN; IMMUNOGLOBULIN; LOOP DIURETIC AGENT; PREDNISOLONE; SPIRONOLACTONE; TICLOPIDINE; TUMOR NECROSIS FACTOR ALPHA; WARFARIN;

ARTICLE; BACTERIAL INFECTION; BLOOD PRESSURE; BREATHING RATE; CASE REPORT; CONVALESCENCE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; DOPPLER ECHOCARDIOGRAPHY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FEVER; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; INFANT; LABORATORY TEST; M MODE ECHOCARDIOGRAPHY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDIAL EFFUSION; PERIPHERAL EDEMA; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; SYSTOLIC HEART MURMUR; TREATMENT OUTCOME; URTICARIA;

ACUTE DISEASE; CONVALESCENCE; CORONARY ANEURYSM; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATRIURETIC PEPTIDE, BRAIN; PLASMA EXCHANGE;

EID: 66549086817     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2009.02832.x     Document Type: Article

References (10)

1. Imagawa T, Mori M, Miyamae T et al. Plasma exchange for refractory Kawasaki disease. Eur. J. Pediatr. 2004 163 : 263 4.
2. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994 90 : 195 203. (Pubitemid 24203680)
3. Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr. Int. 2000 42 : 241 8.
4. Kurotobi S, Kawakami N, Shimizu K et al. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr. Cardiol. 2005 26 : 425 30.
5. Nakamura Y, Yashiro M, Oki I, Tanihara S, Ojima T, Yanagawa H. Giant coronary aneurysms due to Kawasaki disease: A case-control study. Pediatr. Int. 2002 44 : 254 8.
6. Kobayashi T, Inoue Y, Takeuchi K et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006 113 : 2606 12.
7. Burns JC, Mason WH, Hauger SB et al. Infliximab treatment for refractory Kawasaki syndrome. J. Pediatr. 2005 146 : 662 7.
8. Inoue Y, Okada Y, Shinohara M et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome. J. Pediatr. 2006 149 : 336 41.
9. Yoshikawa H, Nomura Y, Masuda K et al. Four cases of Kawasaki syndrome complicated with myocarditis. Circ. J. 2006 70 : 202 5.
10. Omland T, Aakvaag A, Bonarjee VV et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996 93 : 1963 9.